Type 2 diabetes with ASCVD — USMLE Step 3 MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Add a GLP-1 receptor agonist with cardiovascular benefit
In type 2 diabetes with established ASCVD, a GLP-1 receptor agonist or SGLT2 inhibitor with cardiovascular benefit is preferred.
Reference: ADA Standards of Care in Diabetes 2026